{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:03:07Z","timestamp":1781737387604,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejps.2022.106242","type":"journal-article","created":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T09:34:26Z","timestamp":1655631266000},"page":"106242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit\/lead identification"],"prefix":"10.1016","volume":"176","author":[{"given":"Gideon D.","family":"Badenhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kannigadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Aucamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2327-0551","authenticated-orcid":false,"given":"David D.","family":"N'Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106242_bib0001","first-page":"65","article-title":"Hydrazones as promising lead with diversity in bioactivity-therapeutic potential in present scenario","volume":"18","author":"Bala","year":"2013","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.ejps.2022.106242_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for new world cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis","volume":"4","author":"Blum","year":"2012","journal-title":"Int. Health"},{"key":"10.1016\/j.ejps.2022.106242_bib0003","first-page":"e02419","article-title":"Topical treatment for cutaneous leishmaniasis: dermato-pharmacokinetic lead optimization of benzoxaboroles","volume":"62","author":"Bocxlaer","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106242_bib0004","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1128\/AAC.02046-12","article-title":"Evaluating 5-nitrofurans as trypanocidal agents","volume":"57","author":"Bot","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106242_bib0005","unstructured":"CDC (Centers for Disease Control and Prevention). 2022. Parasites - Leishmaniasis; https:\/\/www.cdc.gov\/parasites\/leishmaniasis\/health_professionals\/index.html#dx [Date accessed: 26 June 2022]."},{"key":"10.1016\/j.ejps.2022.106242_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168534","article-title":"Single- and two-electron reduction of nitroaromatic compounds by flavoenzymes: mechanisms and implications for cytotoxicity","volume":"22","author":"\u010c\u0117nas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2022.106242_bib0007","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0960-894X(01)00353-5","article-title":"Benzyloxybenzaldehyde analogues as novel adenylyl cyclase activators","volume":"11","author":"Chang","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106242_bib0008","first-page":"3934","article-title":"Antiparasitic properties of curcumin: a review","volume":"4","author":"Cheraghipour","year":"2018","journal-title":"AIMS Agric. Food"},{"key":"10.1016\/j.ejps.2022.106242_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009181","article-title":"The global procurement landscape of leishmaniasis medicines","volume":"15","author":"Choi","year":"2021","journal-title":"PLoS Negl.Trop. Dis."},{"key":"10.1016\/j.ejps.2022.106242_bib0010","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2022.106242_bib0011","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1371\/journal.pntd.0001253","article-title":"A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit","volume":"5","author":"De Muylder","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejps.2022.106242_bib0012","series-title":"Biomedical Applications of Functionalized Nanomaterials","first-page":"105","article-title":"Chapter 5 - engineered protein variants for bioconjugation","author":"Fernandes","year":"2018"},{"key":"10.1016\/j.ejps.2022.106242_bib0013","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CMR.00092-12","article-title":"Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents","volume":"26","author":"Gonzalez","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2022.106242_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.DMPK-10-RV-062","article-title":"Mechanisms of drug toxicity and relevance to pharmaceutical development","volume":"26","author":"Guengerich","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2022.106242_bib0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting knowledge on leishmania drug resistance to support the quest for new drugs","volume":"33","author":"Hefnawy","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejps.2022.106242_bib0016","first-page":"e4054","article-title":"A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP-1 human acute monocytic leukemia cell line","volume":"70","author":"Jain","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejps.2022.106242_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning","volume":"10","author":"Kaiser","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2022.106242_bib0018","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1002\/anie.200802651","article-title":"Hydrolytic stability of hydrazones and oximes","volume":"47","author":"Kalia","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejps.2022.106242_bib0019","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ddr.21755","article-title":"Synthesis and in vitro antileishmanial efficacy of benzyl analogues of nifuroxazide","volume":"82","author":"Kannigadu","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejps.2022.106242_bib0020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2022.106242_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/pao.2018.1","article-title":"Slow pace of antileishmanial drug development","volume":"4","author":"Kumar A","year":"2018","journal-title":"Parasitol. Open"},{"key":"10.1016\/j.ejps.2022.106242_bib0022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3762\/bjoc.4.13","article-title":"Trifluoromethyl ethers\u2013synthesis and properties of an unusual substituent","volume":"4","author":"Leroux","year":"2008","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejps.2022.106242_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"2001","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2022.106242_bib0024","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejps.2022.106242_bib0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/md15100329","article-title":"Marine-derived penicillium species as producers of cytotoxic metabolites","volume":"15","author":"Liu","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejps.2022.106242_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000280","article-title":"Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives","volume":"354","author":"Mangwegape","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejps.2022.106242_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112146","article-title":"Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents","volume":"191","author":"Mathias","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106242_bib0028","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106242_bib0029","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection","volume":"52","author":"Mookerjee Basu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106242_bib0030","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids","volume":"77","author":"Nepali","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106242_bib0031","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12906-021-03279-1","article-title":"Bio-guided isolation of antileishmanial natural products from Diospyros gracilescens L. (Ebenaceae)","volume":"21","author":"Njanpa","year":"2021","journal-title":"BMC Complement. Med. ther."},{"key":"10.1016\/j.ejps.2022.106242_bib0032","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/jctb.6633","article-title":"Overcoming multi-resistant leishmania treatment by nanoencapsulation of potent antimicrobials","volume":"96","author":"Oliveira","year":"2021","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"10.1016\/j.ejps.2022.106242_bib0033","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1021\/acsmedchemlett.1c00193","article-title":"Monocyclic nitro-heteroaryl nitrones with dual mechanism of activation: synthesis and antileishmanial activity","volume":"12","author":"Pacheco","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106242_bib0034","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.chembiol.2018.12.005","article-title":"5-nitrofurans and cancer: teaching an old drug new tricks","volume":"25","author":"Peterson","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejps.2022.106242_bib0035","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1093\/cid\/ciaa1236","article-title":"Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani","volume":"72","author":"Potvin","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejps.2022.106242_bib0036","first-page":"1","article-title":"An overview on Leishmania vaccines: a narrative review article","volume":"6","author":"Rezvan","year":"2015","journal-title":"Vet. Res. Forum: Int. Q. J."},{"key":"10.1016\/j.ejps.2022.106242_bib0037","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1371\/journal.pntd.0000675","article-title":"Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds","volume":"4","author":"Siqueira-Neto","year":"2010","journal-title":"PLoS Negl.Trop. Dis."},{"key":"10.1016\/j.ejps.2022.106242_bib0038","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1002\/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U","article-title":"The design of leadlike combinatorial libraries","volume":"38","author":"Teague","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejps.2022.106242_bib0039","doi-asserted-by":"crossref","unstructured":"Torres-Guerrero, E., Quintanilla-Cedillo, M.R., Ruiz-Esmenjaud, J., Arenas, R., 2017. Leishmaniasis: a review. F1000Res. 6, 750-750.","DOI":"10.12688\/f1000research.11120.1"},{"key":"10.1016\/j.ejps.2022.106242_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900241","article-title":"Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds","volume":"353","author":"Trefzger","year":"2020","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejps.2022.106242_bib0041","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0031182016002523","article-title":"Chemotherapy of leishmaniasis: present challenges","volume":"145","author":"Uliana","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejps.2022.106242_bib0042","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"van de Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2022.106242_bib0043","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106242_bib0044","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"Vermeersch","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2022.106242_bib0045","unstructured":"WHO, 2022. Leishmaniasis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis [Date of access: 08 January 2022]."},{"key":"10.1016\/j.ejps.2022.106242_bib0046","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2022.106242_bib48","doi-asserted-by":"crossref","first-page":"103587","DOI":"10.1016\/j.bioorg.2020.103587","article-title":"Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues","volume":"96","author":"Zuma","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2022.106242_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200023","article-title":"Synthesis, in vitro antileishmanial efficacy and hit\/lead identification of Nitrofurantoin-triazole hybrids","author":"Zuma","year":"2022","journal-title":"ChemMedChem"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:02:35Z","timestamp":1760529755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":48,"alternative-id":["S0928098722001270"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106242","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit\/lead identification","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106242"}}